Following the arrival of culture results confirming the diagnosis of STI, the antimicrobial regimen was adjusted to include piperacillin/tazobactam, a broad-spectrum beta-lactam/beta-lactamase inhibitor combination effective against a wide range of aerobic and anaerobic bacteria. The gene discussed is LACTB; the disease is sexually transmitted disease.